Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
33421
-
33422
-
33423
-
33424
-
33425
LiCl administration shifts GC taste responses in the direction of a simple “good vs. bad” judgment.
Published 2022“…<p><b>(A)</b> The time course of average correlations (Spearman rank-correlation coefficient) between firing rates and known palatability shows the expected increase as responses reached the late epoch, but this rise reached a higher peak following LiCl (<i>n</i> = 174) than saline injection (<i>n</i> = 136, Kruskal–Wallis H-test, ** <i>p <</i> 0.01). …”
-
33426
Data_Sheet_1_Microbial-Driven Butyrate Regulates Jejunal Homeostasis in Piglets During the Weaning Stage.docx
Published 2019“…We aimed to investigate whether jejunal microbial metabolite butyrate modulates the apoptosis/proliferation balance and immune response in piglets during the post-weaning period of the first 3 weeks of life. On the one hand, during the first week post-weaning, the relative abundances of the dominant bacterial families Erysipelotrichaceae (P < 0.01) and Lachnospiraceae (P < 0.01) were increased, which induced decreases in both butyrate production (P < 0.05) and its receptor (G-protein coupled receptor 43) expression (P < 0.01). …”
-
33427
Cerebral artery geometry and nucleus count of the smooth muscle layer.
Published 2018“…<p>(A) VDD significantly increased the wall thickness (* p<0.05, n = 10–11) as well as (B) the wall thickness / lumen diameter ratio (** p<0.01, n = 10–11). …”
-
33428
-
33429
Image 9_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
33430
Image 6_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
33431
Image 10_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
33432
Image 3_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
33433
Image 8_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
33434
Image 7_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
33435
Image 4_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
33436
Image 5_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
33437
Image 2_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
33438
Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model
Published 2019“…</p><p>Results</p><p>Four weeks after infusing BMSCs, a significant improvement was observed in the Vein group (n = 8) compared to outcome in the Control group (n = 10), along with a decrease in ICG t<sub>1/2</sub>. …”
-
33439
-
33440